Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Julius Wong who wrote (177807)	9/6/2021 1:41:11 PM
From: gg cox	3 Recommendations Recommended By abuelita Julius Wong maceng2 Respond to of 219461

Beyond cool,,, to2 very very cools. river-runner.samlearner.com

To: Julius Wong who wrote (177807)	9/6/2021 1:52:50 PM
From: Cogito Ergo Sum	Respond to of 219461

Further sign of demise

To: Julius Wong who wrote (177807)	9/6/2021 11:35:47 PM
From: TobagoJack	Respond to of 219461

Re <<More Americans are taking jobs without employer benefits like health care or paid vacation>> Need common-prosperity approach? But not likely as guided by the sort akin to AOC and such same, who believe time scale is an election cycle minus 12 months, and slogan substitutes for deliberation. Am agnostic, because the devil is in the details, hiding somewhere if there Meantime WS / Squid is enthusiastic, as is JPM Received in e-mai. Bullish. Dear All, What happened? On Sep 2, President Xi announced that a new stock exchange will soon be launched in Beijing. Shortly after, the CSRC issued a statement outlining the strategic development plan of the new bourse. Inauguration timetable is subject to clarification but should be shorter than the 7-month preparation period by STAR. What is this? Per the CSRC’s statement, the new exchange will initially be formed by a subset (the Select Layer) of National Equity Exchange and Quotations (NEEQ Board) which has been in place since 2013. The Select Layer currently consists of 66 stocks, with a total market cap of US$29bn and ADT of US$43mn, concentrated in Materials and Industrials. The aggregate NEEQ Board contains 7304 companies, representing 2%/0.06% of total A-share market cap/liquidity. Why? (1) With the approval of the MSCI A50 Connect Index Futures less than 2 weeks ago, this is another testament of the Chinese authorities’commitment to liberalizing and reforming the domestic capital markets (e.g. the creation of STAR in Shanghai in Jul 2019, the reform of NEEQ in Oct 2019, the merger of Mainboard and SME board in Shenzhen in Apr 2021); (2) It is consistent with the overarching policy bias of supporting SMEs and direct financing, reducing leverage, fostering innovation, promoting fairer competition, and enhancing regional cooperation; (3) It helps create a better-defined and more diversified capital market structure, and provides a financing platform for early-stage SMEs that currently do not fulfill the listing requirements on ChiNext and STAR, and a potential venue for “home-coming” listing by offshore listed Chinese companies; (4) The likely market microstructure changes and policy endorsement could boost turnover and reduce liquidity premium for Select Layer stocks (and future listings). Market implications? (1) Limited cannibalization risks for other stock exchanges in HK/China until the new bourse becomes scalable given their differentiated strategic positioning (IPO/company size, investor base, currency) ; (2) Thematically, market intermediaries such as brokers could benefit but it’s premature to quantify the impacts in the absence of listing/trading details; (3) The visible capital market reform momentum may help compress regulation risk premium in and drive incremental inflows to A shares, supporting our OW stance on China A in a regional context.

To: Julius Wong who wrote (177807)	9/7/2021 1:03:57 AM
From: TobagoJack	Respond to of 219461

Let’s watch & brief ‘Recombinant protein’ - whatever that be - liquid that showed promise for both preventative as well as therapeutic efficacy across the alphabets in non-human primate studies If good, prospective game-changer, in American English language, or killer-app in silicon valley speak scmp.com China / Science Chinese Covid-19 vaccine gets UAE nod for therapeutic use trial Approval follows earlier green light in the UAE and New Zealand for preventive use trials of YishengBio vaccine Patients with mild to moderate Covid-19 infections will be targeted first in trial of regimen involving two shots seven days apart … In a non-human primate preclinical study, monkeys were infected with coronavirus first before being injected with what Shao called the first therapeutic Covid-19 vaccine in the country, with “promising results”. … Shao said animal serum studies showed the YishengBio vaccine could offer broad and lasting protection against coronavirus variants including Alpha, Beta, Gamma and Lambda even at day 448 post vaccination, indicating good durability of the immune response. With just a week needed to complete the regimen, the vaccine would be potentially very useful during an outbreak.

To: Julius Wong who wrote (177807)	9/7/2021 2:15:15 AM
From: TobagoJack	Read Replies (1) \| Respond to of 219461

Given the geopolitical temperature I wonder where Lotus shall go IPO? bloomberg.com Lotus Tech Studies U.S., Hong Kong IPO to Fund Push Into EVs 7 September 2021, 13:35 GMT+8 Lotus Tech, which develops cars for the Lotus brand, is working on preliminary plans for an initial public offering in the U.S. or Hong Kong to help fund the transition of the iconic maker of sports and racing cars to an all-electric automaker. The company is studying a potential IPO as soon as 2023 if sales go well, Group Lotus Chief Executive Officer Feng Qingfeng said in an interview Tuesday. There’s also the possibility that Lotus Cars will list in the U.K., but no timetable has been set, he said. Lotus Tech, which broke ground on its global headquarters in the Chinese city of Wuhan last week, is tapping the potential for sports cars in the world’s biggest auto market against a small pool of competitors including Porsche Automobil Holding SE and BMW AG. Lotus is part of the auto empire of Li Shufu, who founded Zhejiang Geely Holding Group Co. and has long held ambitions of developing top-end sports cars. The unit plays an important role in the group, which offers diverse products ranging from affordable mass-market vehicles to the ultra-luxury racing cars made by Lotus. Chinese motorists’ appetite for high-performance sports cars has proven to be surprisingly strong, with pre-orders for Lotus’ Emira sports car topping 3,000 since opening on Aug. 20. While a price hasn’t been set, British media has reported the vehicle will start at around 60,000 pounds ($83,000). The demand more than doubled company estimates, Feng said. Lotus’ Emira Source: Lotus Half of Lotus’s total sales may come from China in five years, when annual global deliveries are forecast to reach about 120,000 to 150,000 units a year, he said. Lotus cars made in China will be exported to markets including the U.K., Germany and the Netherlands, starting in 2023, Feng added. Lotus Tech, which last week announced an investment pact with a unit of Chinese EV maker Nio Inc., plans to start another fundraising round at the beginning of next year, Feng said. — With assistance by John Liu, and Ying Tian Before it's here, it's on the Bloomberg Terminal. LEARN MORE

To: Julius Wong who wrote (177807)	9/7/2021 2:22:23 AM
From: TobagoJack	Respond to of 219461

Beijing University is the place to be should on do university in China. Tsinghua is the other, unless one goes full-tech, at Anhui University of Science and Technology for quantum and fusion and such let us watch this kid and see how the story unfolds Shall cheer for him scmp.com Teenager with muscular dystrophy aims to become China’s Stephen Hawking after acceptance into prestigious university Born with congenital muscular dystrophy, Xing Yifan weighs just 18kg and can barely move without help Despite the challenge of his disease he has worked hard with the help of his parents and gained entrance to Beihang University Mandy Zuo in Shanghai Published: 9:00am, 7 Sep, 2021 An 18-year-old man with muscular dystrophy aspires to becoming China’s Stephen Hawking, and has inspired many after being accepted by a top Chinese university. Photo: Artwork An 18-year-old with congenital muscular dystrophy who aspires to become China’s Stephen Hawking has become a celebrity after being accepted by the country’s leading university in astronautics. Xing Yifan, who was diagnosed with muscular dystrophy when only six months old, started studying in Beihang University last week in the company of his mother, China Youth Daily reported over the weekend. “I want to see how far I can go. I want to run forward a little more,” he was quoted as saying. His mother once asked him to change to a less competitive class when in high school. He answered: “If I made it to this class, then I can finish it. I see no reason to quit.” Xing weighs only 18kg and uses a wheelchair with the help of his parents, who must wake every two hours to turn him over. Photo: weixin.qq.com The young man, who is unable to stand or walk and can barely move his neck, was accepted into the respected university with a score of 645 out of 750 in China’s highly competitive college entrance exams, also known as the gaokao. With his bones growing like a normal child but no muscles developing to support them, Xing weighs only 18kg and uses a wheelchair with the help of his parents. In a typical 45-minute class, he can sit for only 30 minutes as his spine is twisted, put his chin on the desk to help support his head, with his eyes only able to see half of a book page due to difficulty in moving his neck. For the rest of the class, he has to lie down and participate by listening. Despite the challenges he faced, his parents made sure he received the same education as other children. Over the years his parents would take turns to be by his side for every single class he took, according to his father Xing Dacheng. Every night, they need to wake up every two hours to help him turn over. Despite the obstacles he faces, Xing had the highest score among all the newly admitted students in his school, a top school in his hometown. Photo weixin.qq.com With the ambition of becoming China’s Stephen Hawking, the English theoretical physicist and cosmologist who suffered a similar disease, Xing has achieved an outstanding academic performance to date. Hawking was diagnosed in his early 20s with a slow-progressing form of motor neurone disease that gradually paralysed him. He died in 2018 after living with the illness for over five decades. Before going to Beijing for college, Xing had the highest score among all the newly admitted students in his school, a top school in his hometown of Jilin city, Jilin province. Xing can only hold his head upright for short periods of time and so a lot of his education has been through listening. Photo: weixin.qq.com Despite deformed fingers, Xing still manages to write. To prepare for the college entrance exams, he spent hours doing writing exercises that would have daunted even the healthiest of teenagers. On some days he would complete more than 20 test papers, the report said. To his parents, his academic achievement is a source of pride after years of hard work raising a child with muscular dystrophy “Every day is a challenge. It’s like a battle. We win when we spend the day smoothly,” his father said. “We dare not think about the future, but we’ll try hard to live well every day.” The university has prepared a two-bed dormitory with a bathroom on the ground floor for Xing and his mother, who will take care of him full time.